AP2006003735A0 - Indentification of self and non-self antigens implicated in autoimmune diseases - Google Patents

Indentification of self and non-self antigens implicated in autoimmune diseases

Info

Publication number
AP2006003735A0
AP2006003735A0 AP2006003735A AP2006003735A AP2006003735A0 AP 2006003735 A0 AP2006003735 A0 AP 2006003735A0 AP 2006003735 A AP2006003735 A AP 2006003735A AP 2006003735 A AP2006003735 A AP 2006003735A AP 2006003735 A0 AP2006003735 A0 AP 2006003735A0
Authority
AP
ARIPO
Prior art keywords
self
indentification
autoimmune diseases
antigens implicated
implicated
Prior art date
Application number
AP2006003735A
Other languages
English (en)
Inventor
James Rasmussen
Bei Yu
Original Assignee
Peptimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptimmune Inc filed Critical Peptimmune Inc
Publication of AP2006003735A0 publication Critical patent/AP2006003735A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0008Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
AP2006003735A 2004-03-11 2005-03-10 Indentification of self and non-self antigens implicated in autoimmune diseases AP2006003735A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/799,005 US7084247B2 (en) 2004-03-11 2004-03-11 Identification of self and non-self antigens implicated in autoimmune diseases
PCT/US2005/008326 WO2005087261A2 (en) 2004-03-11 2005-03-10 Identification of self and non-self antigens implicated in autoimmune diseases

Publications (1)

Publication Number Publication Date
AP2006003735A0 true AP2006003735A0 (en) 2006-10-31

Family

ID=34920407

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003735A AP2006003735A0 (en) 2004-03-11 2005-03-10 Indentification of self and non-self antigens implicated in autoimmune diseases

Country Status (17)

Country Link
US (2) US7084247B2 (xx)
EP (1) EP1732595A2 (xx)
JP (1) JP2007528422A (xx)
KR (1) KR20070026450A (xx)
CN (1) CN1942202A (xx)
AP (1) AP2006003735A0 (xx)
AU (1) AU2005221712A1 (xx)
BR (1) BRPI0508633A (xx)
CA (1) CA2559065A1 (xx)
EA (1) EA200601671A1 (xx)
IL (1) IL177961A0 (xx)
MA (1) MA28525B1 (xx)
MX (1) MXPA06010364A (xx)
NO (1) NO20064610L (xx)
TN (1) TNSN06273A1 (xx)
WO (1) WO2005087261A2 (xx)
ZA (1) ZA200607552B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7084247B2 (en) * 2004-03-11 2006-08-01 Peptimmune, Inc. Identification of self and non-self antigens implicated in autoimmune diseases
US20070093449A1 (en) * 2005-10-14 2007-04-26 De Porre Peter M R Novel IV formulation of tipifarnib
DE602007005349D1 (de) * 2006-01-17 2010-04-29 Organon Nv SELEKTIVE ENZYMATISCHE HYDROLYSE VON C-TERMINALEN tert-BUTYL-PEPTIDESTERN
US8378072B2 (en) * 2006-04-13 2013-02-19 Declion Pharmaceuticals, Inc. Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
JP2009069050A (ja) * 2007-09-14 2009-04-02 Nec Corp 化合物のカラム担体への固定化方法
WO2009051797A1 (en) * 2007-10-16 2009-04-23 Peptimmune, Inc. Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes
NZ589302A (en) * 2008-04-17 2012-11-30 Declion Pharmaceuticals Inc Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
ES2381849T3 (es) 2008-11-17 2012-06-01 Borealis Ag Procedimiento multietapa para producir polietileno con formación de gel reducida
CA2761907A1 (en) * 2009-05-14 2010-11-18 Oatmeal Biotechnologies Group, L.L.C. Platform technologies for spontaneously occurring diseases
GB201112806D0 (en) * 2011-07-26 2011-09-07 Bauer Johann Use of epitopes inducing specific tolerance for the prevention of tissue rejection
EP2570455A1 (en) 2011-09-16 2013-03-20 Borealis AG Polyethylene composition with broad molecular weight distribution and improved homogeneity
EP2599828A1 (en) 2011-12-01 2013-06-05 Borealis AG Multimodal polyethylene composition for the production of pipes with improved slow crack growth resistance
US11458199B2 (en) * 2012-08-21 2022-10-04 Opko Pharmaceuticals, Llc Liposome formulations
EP2730612B1 (en) 2012-11-09 2016-09-14 Abu Dhabi Polymers Company Limited (Borouge) Polymer composition comprising a blend of a multimodal polyethylene and a further ethylene polymer suitable for the production of a drip irrigation pipe
EP2730611B1 (en) 2012-11-09 2017-01-04 Abu Dhabi Polymers Company Limited (Borouge) Drip irrigation pipe comprising a polymer composition comprising a multimodal polyethylene base resin
EP2740761B1 (en) 2012-12-05 2016-10-19 Borealis AG Polyethylene composition with improved balance of slow crack growth resistance, impact performance and pipe pressure resistance for pipe applications
EP2860200B1 (en) 2013-10-10 2017-08-02 Borealis AG Polyethylene composition for pipe and pipe coating applications
EP2860204B1 (en) 2013-10-10 2018-08-01 Borealis AG Polyethylene composition for pipe applications
PL2860202T3 (pl) 2013-10-10 2018-11-30 Borealis Ag Polietylen odporny na wysoką temperaturę i sposób jego wytwarzania
EP2860201A1 (en) 2013-10-10 2015-04-15 Borealis AG High temperature resistant polyethylene and process for the production thereof
US10801070B2 (en) 2013-11-25 2020-10-13 The Broad Institute, Inc. Compositions and methods for diagnosing, evaluating and treating cancer
WO2015085147A1 (en) 2013-12-05 2015-06-11 The Broad Institute Inc. Polymorphic gene typing and somatic change detection using sequencing data
US20160310584A1 (en) * 2013-12-06 2016-10-27 The Broad Institute Inc. Formulations for neoplasia vaccines
KR20160101073A (ko) 2013-12-20 2016-08-24 더 브로드 인스티튜트, 인코퍼레이티드 신생항원 백신과의 병용 요법
US10301370B2 (en) * 2014-05-02 2019-05-28 The Trustees Of The University Of Pennsylvania Compositions and methods of chimeric autoantibody receptor T cells
US10975442B2 (en) 2014-12-19 2021-04-13 Massachusetts Institute Of Technology Molecular biomarkers for cancer immunotherapy
US10993997B2 (en) 2014-12-19 2021-05-04 The Broad Institute, Inc. Methods for profiling the t cell repertoire
MY190974A (en) 2015-05-20 2022-05-25 Massachusetts Gen Hospital Shared neoantigens
WO2018140391A1 (en) 2017-01-24 2018-08-02 The Broad Institute, Inc. Compositions and methods for detecting a mutant variant of a polynucleotide
KR102593922B1 (ko) 2018-10-31 2023-10-25 보레알리스 아게 개선된 균질성을 갖는 고압력 저항성 파이프용 폴리에틸렌 조성물
EP3647645A1 (en) 2018-10-31 2020-05-06 Borealis AG Polyethylene composition for high pressure resistant pipes
AU2019388183B2 (en) 2018-11-28 2022-03-24 Abu Dhabi Polymers Co. Ltd (Borouge) L.L.C. Polyethylene composition for film applications
US20220282074A1 (en) 2019-07-22 2022-09-08 Abu Dhabi Polymers Co. Ltd (Borouge) L.L.C., Single site catalysed multimodal polyethylene composition
EP4019583B1 (en) 2020-12-28 2024-04-10 ABU DHABI POLYMERS CO. LTD (BOROUGE) - Sole Proprietorship L.L.C. Polyethylene composition for film applications with improved toughness and stiffness

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973577A (en) * 1986-04-04 1990-11-27 The Salk Institute For Biological Studies FSH-releasing peptides
US5260422A (en) 1988-06-23 1993-11-09 Anergen, Inc. MHC conjugates useful in ameliorating autoimmunity
US5194425A (en) * 1988-06-23 1993-03-16 Anergen, Inc. Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
US5130297A (en) * 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
WO1990008161A1 (en) 1989-01-12 1990-07-26 The Blood Center Of Southeastern Wisconsin Peptide-mediated modulation of t-cell recognition as a means of affecting immune responses
CA2106567A1 (en) 1991-03-22 1992-09-23 William V. Williams Method of modulating mammalian t-cell response
AU3178393A (en) 1991-11-27 1993-06-28 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Nucleotide and amino acid sequence of pemphigus vulgaris antigen and methods of use
US5719064A (en) 1992-08-31 1998-02-17 Oklahoma Medical Research Foundation Peptide diagnostics and therapeutics for spondyloarthropathies
AU4851893A (en) 1992-09-11 1994-04-12 Washington University Peptides tolerizing t-cells and compositions thereof
EP0726708A1 (en) 1993-11-05 1996-08-21 Pathogenesis Corporation Virus associated multiple sclerosis: treatments, prevention and diagnosis thereof
US6329499B1 (en) * 1994-11-18 2001-12-11 Neurocrine Biosciences, Inc. Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein
US5874531A (en) * 1995-03-07 1999-02-23 President And Fellows Of Harvard College Identification of self and non-self antigens implicated autoimmune disease
AU767185B2 (en) * 1998-03-23 2003-11-06 President And Fellows Of Harvard College Synthesis of compounds and libraries of compounds
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US7084247B2 (en) * 2004-03-11 2006-08-01 Peptimmune, Inc. Identification of self and non-self antigens implicated in autoimmune diseases

Also Published As

Publication number Publication date
KR20070026450A (ko) 2007-03-08
AU2005221712A1 (en) 2005-09-22
CN1942202A (zh) 2007-04-04
BRPI0508633A (pt) 2007-08-07
TNSN06273A1 (en) 2007-12-03
US20060159672A1 (en) 2006-07-20
ZA200607552B (en) 2008-05-28
US7084247B2 (en) 2006-08-01
JP2007528422A (ja) 2007-10-11
WO2005087261A3 (en) 2005-12-08
WO2005087261A2 (en) 2005-09-22
MXPA06010364A (es) 2007-03-07
US20050202034A1 (en) 2005-09-15
MA28525B1 (fr) 2007-04-03
EA200601671A1 (ru) 2007-02-27
NO20064610L (no) 2006-12-04
IL177961A0 (en) 2006-12-31
CA2559065A1 (en) 2005-09-22
EP1732595A2 (en) 2006-12-20

Similar Documents

Publication Publication Date Title
AP2006003735A0 (en) Indentification of self and non-self antigens implicated in autoimmune diseases
EP1827391A4 (en) DOSAGE FORMS AND METHODS OF USE THEREOF
HK1099935A1 (en) Anti-cd3 antibodies and methods of use thereof -cd3
IL213843A0 (en) 4-aminotetracyclines and methods of use thereof
IL179476A0 (en) Antibodies against human interleukin-13 and uses therefor
TWI318767B (en) 3t1d memory cells using gated diodes and methods of use thereof
EP1778210A4 (en) CONJUGATES OF FATTY ACID AND AMINO ACIDS AND METHODS OF USE
ZA200607749B (en) Preparation of canola protein isolate and use in aquaculture
EP1794589A4 (en) PROTEIN ARRAYS AND METHOD OF USE THEREOF
IL199045A0 (en) Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
IL179140A0 (en) Antibody drug conjuates and methods
IL177193A0 (en) Anti-cd3 and antigen -specific immunotherapy to treat autoimmunity
IL180817A0 (en) Specific inhibition of autoimmunity and diseases associated with autoantigens
HK1104563A1 (en) Estrogen receptors and methods of use
EP1789047A4 (en) PROCESS FOR TREATING DISEASES USING NALMEFENE AND ITS ANALOGUES
ZA200902419B (en) Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
EP1789027A4 (en) Therapeutic Use of Anti- TF Antigen Antibodies
EP1853632A4 (en) MODIFICATION OF AMINES AND ALCOHOLS
EP1950565A4 (en) METHOD FOR DETERMINING ANTIGEN AND KIT USABLE IN THE METHOD
EP1735281A4 (en) SYNTHESIS OF INDENOISOQUINOLINIUMS AND TECHNIQUES OF USE
EP1740120A4 (en) LONG-TERM FORMULATIONS OF NALTREXONE AND METHOD OF USE
EP1848806A4 (en) ANTI-T CELL AND AUTOANTIGEN TREATMENT OF AN AUTOIMMUNE DISEASE
EP1776126A4 (en) METHOD FOR THE USE OF REGENERATIVE CELLS IN THE TREATMENT OF STROKE AND RELATED DISEASES AND DISORDERS
HK1155670A1 (en) Therapeutic use of anti-cs1 antibodies
IL177868A0 (en) Anti-inflammatory peptides and methods of use thereof